SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
Palabras clave :
Área de Medicina Clínica y Epidemiología
Osteosarcoma
Pharmacogenetics
Doxorubicin
L-type amino acid transporter 2
Early disease progression
Fecha de publicación :
2022
Nota:
This is an
open-access article distributed under the
terms of the Creative Commons Attribution
License (CC BY). The use, distribution or
reproduction in other forums is permitted,
provided the original author(s) and the
copyright owner(s) are credited and that the
original publication in this journal is cited, in
accordance with accepted academic practice.
No use, distribution or reproduction is
permitted which does not comply with these
terms.
Cita:
Hurkmans, E. G. E.; Koenderink, J. B.; an den Heuvel, J. J. M. W.; et al. "SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin". Frontiers In Pharmacology. 13, 2022, 1042989
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.